Imaging of vulnerable atherosclerotic plaques with FDG-microPET: no FDG accumulation

Jacob Marsvin Laurberg1, Aage Kristian Olsen, Søren Baarsgaard Hansen

  • 1Department of Cardiology and Institute of Clinical Medicine, Aarhus University Hospital (Skejby), Aarhus, Denmark. jlaurberg@ki.au.dk <jlaurberg@ki.au.dk>

Atherosclerosis
|August 22, 2006
PubMed
Abstract

Insights

Fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging did not detect advanced atherosclerosis in mouse aortas or carotids. This study questions FDG-PET

Area of Science:

  • Cardiovascular Research
  • Medical Imaging
  • Experimental Medicine

Background:

  • Non-invasive imaging methods are crucial for assessing atherosclerosis in both human patients and animal models.
  • Previous studies suggested that FDG-PET could identify vulnerable, inflamed atherosclerotic plaques.

Purpose of the Study:

  • To evaluate the utility of FDG-PET for detecting atherosclerosis in apoE-deficient mice.
  • To determine if FDG-PET can visualize advanced atherosclerotic lesions and assess inflammation.

Main Methods:

  • Atherosclerotic apoE-deficient mice underwent FDG-PET scans.
  • FDG uptake was measured in various tissues, including atherosclerotic aortas, under fasting and non-fasting conditions.
  • Accelerated atherosclerosis was induced via carotid ligation to assess FDG uptake in these lesions.

Main Results:

  • FDG accumulation was observed but primarily attributed to interscapular brown fat, not atherosclerotic lesions.
  • Aortic arch FDG uptake was paradoxically lower than in non-atherosclerotic thoracic aorta in both fasting and non-fasting states.
  • Induced carotid atherosclerosis did not result in increased FDG uptake compared to non-ligated arteries.

Conclusions:

  • Advanced atherosclerotic lesions in the aorta showed reduced FDG uptake, contrary to expectations.
  • FDG-PET imaging failed to detect accelerated atherosclerosis in the carotid arteries.
  • These findings challenge the effectiveness of FDG-PET for imaging advanced, vulnerable atherosclerotic lesions.

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...